Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A

被引：3

作者：

Repesse, Yohann ^{[1
,2
,3
]}

Costa, Catherine ^{[4
]}

Palla, Roberta ^{[5
]}

Moshai, Elika Farrokhi ^{[6
]}

Borel-Derlon, Annie ^{[1
,2
,3
]}

D'Oiron, Roseline ^{[7
]}

Rothschild, Chantal ^{[8
]}

El-Beshlawy, Amal ^{[9
]}

Elalfy, Mohsen ^{[10
]}

Ramanan, Vijay ^{[11
]}

Eshghi, Peyman ^{[12
]}

Oldenburg, Johannes ^{[13
]}

Pavlova, Anna ^{[13
]}

Rosendaal, Frits R. ^{[14
]}

Peyvandi, Flora ^{[5
]}

Kaveri, Srinivas V. ^{[6
]}

Lacroix-Desmazes, Sebastien ^{[6
]}

机构：

[1] CHU Caen, Hematol Lab, Caen, France

[2] INSERM, U1237, GIP Cyceron, Caen, France

[3] Normandie Univ, UNI CAEN, UFR Sante, Caen, France

[4] Grp Hosp Cochin Broca, AP HP, Hotel Dieu, Serv Genet & Biol Mol, Site Cochin, Paris, France

[5] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[6] Univ Paris Diderot, Sorbonne Univ, USPC, Ctr Rech Cordeliers,INSERM, Paris, France

[7] AP HP, Ctr Traitement Hemophilie, Le Kremlin Bicetre, France

[8] Hop Necker Enfants Malad, AP HP, Ctr Traitement Hemophilie, Paris, France

[9] Cairo Univ, Pediat Hosp, Pediat Hematol Dept, Cairo, Egypt

[10] Cairo Univ, Ain Shams Ctr, Dept Pediat, Fac Med, Cairo, Egypt

[11] Jehangir Hosp Premises, Jehangir Clin Dev Ctr, Dept Hematol, Pune, Maharashtra, India

[12] Shahid Beheshti Univ Med Sci, Pediat Congenital Hematol Disorders Res Ctr, Tehran, Iran

[13] Univ Clin Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany

[14] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands

来源：

HAEMATOLOGICA | 2019年 / 104卷 / 08期

关键词：

COAGULATION FACTOR-VIII; VONWILLEBRAND-FACTOR; FACTOR GENE; POLYMORPHISMS; MUTATIONS; IMMUNOGENICITY; ANTIBODIES; FVIII;

D O I：

10.3324/haematol.2018.212001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E369 / E372

页数：4

共 50 条

[1] High concentrations of coagulation factor VIII and thrombosis: is the factor VIII-binding domain of von Willebrand factor implicated?
Bowen, DJ
Maclean, RM
Pellard, S
Collins, PW
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) : 655 - 657
[2] Significance of endogenous von Willebrand factor in development of factor VIII immune responses in severe experimental hemophilia A
Gangadharan, B.
Ing, M.
Delignaut, S.
Christophe, O.
Kaveri, S.
Lacroix-desmazes, S.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 835 - 835
[3] Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity
Oldenburg, Johannes
Lacroix-Desmazes, Sebastien
Lillicrap, David
HAEMATOLOGICA, 2015, 100 (02) : 149 - 156
[4] Primary structure of the propeptide and factor VIII-binding domain of bovine von Willebrand factor
Janel, N
Ribba, AS
Cherel, G
KerbiriouNabias, D
Meyer, D
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1339 (01): : 4 - 8
[5] Factor VIII inhibitors:: role of von Willebrand factor on the uptake of factor VIII by dendritic cells
Kaveri, S. V.
Dasgupta, S.
Andre, S.
Navarrete, A. -M.
Repesse, Y.
Wootla, B.
Lacroix-Desmazes, S.
HAEMOPHILIA, 2007, 13 : 61 - 64
[6] von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A Patients
van Moort, Iris
Bukkems, Laura H.
Heijdra, Jessica M.
Schutgens, Roger E. G.
Laros-van Gorkom, Britta A. P.
Nieuwenhuizen, Laurens
van der Meer, Felix J. M.
Fijnvandraat, Karin
Ypma, Paula
de Maat, Moniek P. M.
Leebeek, FrankW. G.
Meijer, Karina
Eikenboom, Jeroen
Mathot, Ron A. A.
Cnossen, Marjon H.
THROMBOSIS AND HAEMOSTASIS, 2020, 120 (07) : 1056 - 1065
[7] Combined hemophilia A and type 2N von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor
Casonato, A
Pontara, E
Sartorello, F
Gemmati, D
Cattini, MG
Girolami, A
HAEMATOLOGICA, 2001, 86 (10) : 1110 - 1111
[8] Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII
Gensana, M
Altisent, C
Aznar, JA
Casaña, P
Hernández, F
Jorquera, JI
Magallón, M
Massot, M
Puig, L
HAEMOPHILIA, 2001, 7 (04) : 369 - 374
[9] Impact of capacity-limited binding on recombinant factor VIII and von Willebrand factor pharmacokinetics in hemophilia A rats
Christensen, Isabell Vargas
Loftager, Mette
Rode, Frederik
Nielsen, Hanne Morck
Kreilgaard, Mads
Larsen, Malte Selch
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (06) : 964 - 974
[10] Factor VIII and von Willebrand factor
Vlot, AJ
Koppelman, SJ
Bouma, BN
Sixma, JJ
THROMBOSIS AND HAEMOSTASIS, 1998, 79 (03) : 456 - 465

← 1 2 3 4 5 →